89 related articles for article (PubMed ID: 14970586)
1. Delivery of DNA to pulmonary endothelium using adenoviral vectors.
Reynolds PN
Methods Mol Biol; 2004; 246():69-89. PubMed ID: 14970586
[TBL] [Abstract][Full Text] [Related]
2. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.
Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW
Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546
[TBL] [Abstract][Full Text] [Related]
3. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.
Reynolds PN; Zinn KR; Gavrilyuk VD; Balyasnikova IV; Rogers BE; Buchsbaum DJ; Wang MH; Miletich DJ; Grizzle WE; Douglas JT; Danilov SM; Curiel DT
Mol Ther; 2000 Dec; 2(6):562-78. PubMed ID: 11124057
[TBL] [Abstract][Full Text] [Related]
4. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.
Morrell NW; Yang X; Upton PD; Jourdan KB; Morgan N; Sheares KK; Trembath RC
Circulation; 2001 Aug; 104(7):790-5. PubMed ID: 11502704
[TBL] [Abstract][Full Text] [Related]
5. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.
Reynolds AM; Holmes MD; Danilov SM; Reynolds PN
Eur Respir J; 2012 Feb; 39(2):329-43. PubMed ID: 21737550
[TBL] [Abstract][Full Text] [Related]
6. Delivery of DNA to lung airway epithelium.
Weiss DJ
Methods Mol Biol; 2004; 246():53-68. PubMed ID: 14970585
[TBL] [Abstract][Full Text] [Related]
7. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.
Thomson JR; Machado RD; Pauciulo MW; Morgan NV; Humbert M; Elliott GC; Ward K; Yacoub M; Mikhail G; Rogers P; Newman J; Wheeler L; Higenbottam T; Gibbs JS; Egan J; Crozier A; Peacock A; Allcock R; Corris P; Loyd JE; Trembath RC; Nichols WC
J Med Genet; 2000 Oct; 37(10):741-5. PubMed ID: 11015450
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.
; Lane KB; Machado RD; Pauciulo MW; Thomson JR; Phillips JA; Loyd JE; Nichols WC; Trembath RC
Nat Genet; 2000 Sep; 26(1):81-4. PubMed ID: 10973254
[TBL] [Abstract][Full Text] [Related]
9. Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo.
Reynolds PN; Nicklin SA; Kaliberova L; Boatman BG; Grizzle WE; Balyasnikova IV; Baker AH; Danilov SM; Curiel DT
Nat Biotechnol; 2001 Sep; 19(9):838-42. PubMed ID: 11533642
[TBL] [Abstract][Full Text] [Related]
10. Redirecting adenovirus to pulmonary endothelium by cationic liposomes.
Ma Z; Mi Z; Wilson A; Alber S; Robbins PD; Watkins S; Pitt B; Li S
Gene Ther; 2002 Feb; 9(3):176-82. PubMed ID: 11859420
[TBL] [Abstract][Full Text] [Related]
11. Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors.
Schneider DB; Sassani AB; Vassalli G; Driscoll RM; Dichek DA
J Vasc Surg; 1999 Mar; 29(3):543-50. PubMed ID: 10069919
[TBL] [Abstract][Full Text] [Related]
12. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
[TBL] [Abstract][Full Text] [Related]
13. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
[TBL] [Abstract][Full Text] [Related]
14. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
Feng F; Harper RL; Reynolds PN
Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
[TBL] [Abstract][Full Text] [Related]
15. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
16. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector.
Steg PG; Feldman LJ; Scoazec JY; Tahlil O; Barry JJ; Boulechfar S; Ragot T; Isner JM; Perricaudet M
Circulation; 1994 Oct; 90(4):1648-56. PubMed ID: 7923648
[TBL] [Abstract][Full Text] [Related]
17. Delivery of adenoviral DNA to mouse liver.
Connelly S; Mech C
Methods Mol Biol; 2004; 246():37-52. PubMed ID: 14970584
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector.
Dong JY; Wang D; Van Ginkel FW; Pascual DW; Frizzell RA
Hum Gene Ther; 1996 Feb; 7(3):319-31. PubMed ID: 8835219
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension: remodeling revisited.
Eickelberg O; Morty RE
Trends Cardiovasc Med; 2007 Nov; 17(8):263-9. PubMed ID: 18021936
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats.
Partovian C; Adnot S; Raffestin B; Louzier V; Levame M; Mavier IM; Lemarchand P; Eddahibi S
Am J Respir Cell Mol Biol; 2000 Dec; 23(6):762-71. PubMed ID: 11104729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
